These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 28246928

  • 1. Raloxifene Improves Bone Mechanical Properties in Mice Previously Treated with Zoledronate.
    Meixner CN, Aref MW, Gupta A, McNerny EMB, Brown D, Wallace JM, Allen MR.
    Calcif Tissue Int; 2017 Jul; 101(1):75-81. PubMed ID: 28246928
    [Abstract] [Full Text] [Related]

  • 2. Zoledronate treatment has different effects in mouse strains with contrasting baseline bone mechanical phenotypes.
    Aref MW, McNerny EM, Brown D, Jepsen KJ, Allen MR.
    Osteoporos Int; 2016 Dec; 27(12):3637-3643. PubMed ID: 27439372
    [Abstract] [Full Text] [Related]

  • 3. Zoledronate and Raloxifene combination therapy enhances material and mechanical properties of diseased mouse bone.
    Powell KM, Skaggs C, Pulliam A, Berman A, Allen MR, Wallace JM.
    Bone; 2019 Oct; 127():199-206. PubMed ID: 31233931
    [Abstract] [Full Text] [Related]

  • 4. Effects of combination treatment with alendronate and raloxifene on skeletal properties in a beagle dog model.
    Allen MR, McNerny E, Aref M, Organ JM, Newman CL, McGowan B, Jang T, Burr DB, Brown DM, Hammond M, Territo PR, Lin C, Persohn S, Jiang L, Riley AA, McCarthy BP, Hutchins GD, Wallace JM.
    PLoS One; 2017 Oct; 12(8):e0181750. PubMed ID: 28793321
    [Abstract] [Full Text] [Related]

  • 5. Ex vivo exposure to calcitonin or raloxifene improves mechanical properties of diseased bone through non-cell mediated mechanisms.
    Surowiec RK, Saldivar R, Rai RK, Metzger CE, Jacobson AM, Allen MR, Wallace JM.
    Bone; 2023 Aug; 173():116805. PubMed ID: 37196853
    [Abstract] [Full Text] [Related]

  • 6. Bisphosphonate-induced reductions in rat femoral bone energy absorption and toughness are testing rate-dependent.
    Smith ER, Allen MR.
    J Orthop Res; 2013 Aug; 31(8):1317-22. PubMed ID: 23494860
    [Abstract] [Full Text] [Related]

  • 7. Raloxifene reduces skeletal fractures in an animal model of osteogenesis imperfecta.
    Berman AG, Wallace JM, Bart ZR, Allen MR.
    Matrix Biol; 2016 Aug; 52-54():19-28. PubMed ID: 26707242
    [Abstract] [Full Text] [Related]

  • 8. Raloxifene enhances vertebral mechanical properties independent of bone density.
    Allen MR, Iwata K, Sato M, Burr DB.
    Bone; 2006 Nov; 39(5):1130-1135. PubMed ID: 16814622
    [Abstract] [Full Text] [Related]

  • 9. Short-courses of dexamethasone abolish bisphosphonate-induced reductions in bone toughness.
    Luo TD, Allen MR.
    Bone; 2013 Sep; 56(1):199-203. PubMed ID: 23774445
    [Abstract] [Full Text] [Related]

  • 10. Zoledronate effects on systemic and jaw osteopenias in ovariectomized periostin-deficient mice.
    Bonnet N, Lesclous P, Saffar JL, Ferrari S.
    PLoS One; 2013 Sep; 8(3):e58726. PubMed ID: 23505553
    [Abstract] [Full Text] [Related]

  • 11. High-dose zoledronic acid impacts bone remodeling with effects on osteoblastic lineage and bone mechanical properties.
    Pozzi S, Vallet S, Mukherjee S, Cirstea D, Vaghela N, Santo L, Rosen E, Ikeda H, Okawa Y, Kiziltepe T, Schoonmaker J, Xie W, Hideshima T, Weller E, Bouxsein ML, Munshi NC, Anderson KC, Raje N.
    Clin Cancer Res; 2009 Sep 15; 15(18):5829-39. PubMed ID: 19737962
    [Abstract] [Full Text] [Related]

  • 12. Cancer treatment dosing regimens of zoledronic acid result in near-complete suppression of mandible intracortical bone remodeling in beagle dogs.
    Allen MR, Kubek DJ, Burr DB.
    J Bone Miner Res; 2010 Jan 15; 25(1):98-105. PubMed ID: 19580463
    [Abstract] [Full Text] [Related]

  • 13. The effects of strength training and raloxifene on bone health in aging ovariectomized rats.
    Stringhetta-Garcia CT, Singulani MP, Santos LF, Louzada MJ, Nakamune AC, Chaves-Neto AH, Rossi AC, Ervolino E, Dornelles RC.
    Bone; 2016 Apr 15; 85():45-54. PubMed ID: 26812611
    [Abstract] [Full Text] [Related]

  • 14. Combination treatment with eldecalcitol (ED-71) and raloxifene improves bone mechanical strength by suppressing bone turnover and increasing bone mineral density in ovariectomized rats.
    Takeda S, Sakai S, Shiraishi A, Koike N, Mihara M, Endo K.
    Bone; 2013 Mar 15; 53(1):167-73. PubMed ID: 23232307
    [Abstract] [Full Text] [Related]

  • 15. Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra.
    Allen MR, Gineyts E, Leeming DJ, Burr DB, Delmas PD.
    Osteoporos Int; 2008 Mar 15; 19(3):329-37. PubMed ID: 18094911
    [Abstract] [Full Text] [Related]

  • 16. Raloxifene improves skeletal properties in an animal model of cystic chronic kidney disease.
    Newman CL, Creecy A, Granke M, Nyman JS, Tian N, Hammond MA, Wallace JM, Brown DM, Chen N, Moe SM, Allen MR.
    Kidney Int; 2016 Jan 15; 89(1):95-104. PubMed ID: 26489025
    [Abstract] [Full Text] [Related]

  • 17. Recent Advances in Understanding Bisphosphonate Effects on Bone Mechanical Properties.
    Allen MR.
    Curr Osteoporos Rep; 2018 Apr 15; 16(2):198-204. PubMed ID: 29497927
    [Abstract] [Full Text] [Related]

  • 18. Skeletal effects of zoledronic acid in an animal model of chronic kidney disease.
    Allen MR, Chen NX, Gattone VH, Chen X, Carr AJ, LeBlanc P, Brown D, Moe SM.
    Osteoporos Int; 2013 Apr 15; 24(4):1471-81. PubMed ID: 22907737
    [Abstract] [Full Text] [Related]

  • 19. The effect of zoledronate during bone healing.
    Matos MA, Tannuri U, Guarniero R.
    J Orthop Traumatol; 2010 Mar 15; 11(1):7-12. PubMed ID: 20169393
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.